Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$18.78M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
274.7%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$12.96M
Q3 2024
Cash
Q3 2024
P/E
-0.2608
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $0.00 $0.00 $0.00 $0.00 $120.0K
YoY Change -100.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $0.00 $0.00 $0.00 $0.00 $120.0K
Cost Of Revenue
Gross Profit -$2.265M
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $10.03M $9.962M $12.36M $4.101M $3.870M
YoY Change 0.64% -19.4% 201.39% 5.97%
% of Gross Profit
Research & Development $7.066M $6.930M $14.20M $4.218M $6.367M
YoY Change 1.96% -51.18% 236.56% -33.75%
% of Gross Profit
Depreciation & Amortization $37.00K $60.00K $106.0K $46.00K $51.00K
YoY Change -38.33% -43.4% 130.43% -9.8%
% of Gross Profit
Operating Expenses $17.13M $34.46M $26.56M $8.319M $10.24M
YoY Change -50.3% 29.77% 219.22% -18.74%
Operating Profit -$17.13M -$34.46M -$26.56M
YoY Change -50.3% 29.77%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense $5.311M $12.00K $998.0K $2.581M -$1.366M
YoY Change 44158.33% -98.8% -61.33% -288.95%
% of Operating Profit
Other Income/Expense, Net $0.00 $16.88M -$1.821M -$573.0K $0.00
YoY Change -100.0% -1027.18% 217.8%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income -$11.82M -$17.58M -$26.52M -$6.419M -$18.98M
YoY Change -32.77% -33.7% 313.07% -66.17%
Income Tax $83.00K -$1.521M $133.0K $198.0K -$4.577M
% Of Pretax Income
Net Earnings -$20.42M -$16.06M -$26.65M -$6.602M -$14.31M
YoY Change 27.14% -39.74% 303.64% -53.87%
Net Earnings / Revenue -11927.5%
Basic Earnings Per Share -$10.26 -$2.21 -$4.19
Diluted Earnings Per Share -$10.26 -$2.21 -$4.191M -$817.5K -$1.772M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $222.0K $2.080M $19.61M $366.0K $1.584M
YoY Change -89.33% -89.39% 5257.38% -76.89%
Cash & Equivalents $166.0K $2.029M $19.56M $298.0K $1.524M
Short-Term Investments $56.00K $51.00K $53.00K $68.00K $60.00K
Other Short-Term Assets $803.0K $2.017M $101.0K $275.0K $430.0K
YoY Change -60.19% 1897.03% -63.27% -36.05%
Inventory
Prepaid Expenses
Receivables $95.00K
Other Receivables $1.234M
Total Short-Term Assets $1.971M $4.968M $21.05M $1.715M $3.343M
YoY Change -60.33% -76.4% 1127.64% -48.7%
Property, Plant & Equipment $20.00K $27.00K $94.00K $352.0K $437.0K
YoY Change -25.93% -71.28% -73.3% -19.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $350.0K $845.0K $137.0K
YoY Change -100.0% -58.58% 516.79%
Other Assets
YoY Change
Total Long-Term Assets $9.891M $9.576M $28.58M $31.69M $28.26M
YoY Change 3.29% -66.49% -9.81% 12.11%
Total Assets $11.86M $14.54M $49.63M $33.40M $31.61M
YoY Change
Accounts Payable $8.416M $6.251M $698.0K $2.116M $2.178M
YoY Change 34.63% 795.56% -67.01% -2.85%
Accrued Expenses $1.309M $1.912M $8.688M $1.949M $1.962M
YoY Change -31.54% -77.99% 345.77% -0.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.644M $0.00 $1.411M $536.0K
YoY Change -100.0% -100.0% 163.25%
Long-Term Debt Due $1.300M
YoY Change
Total Short-Term Liabilities $14.17M $11.22M $20.72M $5.533M $4.719M
YoY Change 26.24% -45.84% 274.46% 17.25%
Long-Term Debt $0.00 $1.083M $979.0K $880.0K $0.00
YoY Change -100.0% 10.62% 11.25%
Other Long-Term Liabilities $0.00 $7.190M $416.0K $4.134M
YoY Change -100.0% 1628.37% -89.94%
Total Long-Term Liabilities $0.00 $1.083M $8.169M $1.296M $4.134M
YoY Change -100.0% -86.74% 530.32% -68.65%
Total Liabilities $14.61M $12.65M $30.85M $8.964M $13.52M
YoY Change 15.48% -58.98% 244.14% -33.7%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding 1.991M shares 9.527M shares 6.359M shares
Diluted Shares Outstanding 1.991M shares 9.527M shares 6.359M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $4.8991 Million

About Allarity Therapeutics, Inc.

Allarity Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Boston, Massachusetts and currently employs 5 full-time employees. The company went IPO on 2021-12-21. Allarity Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The firm is focused on development of stenoparib, a poly-ADP-ribose polymerase/Tankyrase inhibitor for advanced ovarian cancer patients, using its DRP companion diagnostic for patient selection in the ongoing phase 2 clinical trial, NCT03878849. The company has in-licensed the intellectual property rights to develop, use and market stenoparib. Its DRP companion diagnostic platform is a predictive biomarker technology that employs complex systems biology and bio-analytics with a clinical relevance filter to bridge the gap between in vitro cancer cell responsiveness to a given therapeutic candidate and in vivo likelihood of actual patient benefit from that therapeutic candidate. Its DRP companion diagnostic platform provides a gene expression signature, which reveals whether a specific tumor in a specific patient is likely to respond to one of its therapeutic candidates.

Industry: Pharmaceutical Preparations Peers: Protagenic Therapeutics, Inc.\new PLUS THERAPEUTICS, INC. CervoMed Inc. Salarius Pharmaceuticals, Inc. Tharimmune, Inc. LIXTE BIOTECHNOLOGY HOLDINGS, INC. Qualigen Therapeutics, Inc. ProtoKinetix, Inc.